arrow
T

Thanh H. Dellinger

city of hope
H指数:26
被引数:1,957

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapy

低级别浆液性卵巢癌患者接受腹腔化疗过程中的差异致癌信号通路和免疫微环境变化

2025-12-140
OAAI
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. Antioxidants 2025, 14, 345

更正:Senguttuvan等人。白藜芦醇的抗肿瘤作用在子宫内膜癌中的研究:一项使用甲地孕酮醋酸盐的II期前瞻性、随机、机会窗口临床研究。Antioxidants 2025, 14, 345

2025-12-100
OAAI
Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: trial in progress

多中心剂量递减I期临床试验:在复发性卵巢癌患者中采用加压腹腔内气溶胶化疗(PIPAC)联合nab-紫杉醇和顺铂,并联合全身nab-紫杉醇给药方案:试验进行中

2025-12-010
PRE
ASO Visual Abstract: Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian Cancer Patients with Peritoneal Metastases-A Multicenter US Phase I Trial

ASO视觉摘要:顺铂和柔红霉素加压腹腔气溶胶化疗(PIPAC)在伴有腹膜转移的卵巢癌患者中的安全性与有效性——一项多中心美国I期临床试验

2025-10-010
PRE
Safety and Efficacy of Cisplatin and Doxorubicin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients with Ovarian Cancer with Peritoneal Metastases: A Multicenter US Phase I Trial

顺铂和柔红霉素加压腹腔内气溶胶化疗(PIPAC)在伴有腹膜转移的卵巢癌患者中的安全性与有效性:一项美国多中心I期临床试验

2025-09-300
OA
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate

白藜芦醇在子宫内膜癌中的抗肿瘤作用:一项与美格司特醋酸盐对照的II期前瞻性、随机化、机会窗口临床试验

2025-03-140
OA
Pressurized intraperitoneal aerosolized chemotherapy (PIPAC) experience in patients with recurrent low grade serous ovarian carcinoma (LGSOC): sub-cohort report of phase 1 clinical trial
2024-08-011
OAAI
ASO Visual Abstract: Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer
2023-10-160
PRE
Impact of Sodium Thiosulfate on Prevention of Nephrotoxicities in HIPEC: An Ancillary Evaluation of Cisplatin-Induced Toxicities in Ovarian Cancer
2023-09-147
OAAI
ASO Visual Abstract: Safety and Efficacy of Oxaliplatin Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Colorectal and Appendiceal Cancer with Peritoneal Metastases: Results of a Multicenter Phase I Trial in the United States
2023-08-190
PRE